Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引：3

作者：

He, Rong ^{[1
]}

Chiou, Jonathan ^{[2
]}

Chiou, Allison ^{[3
]}

Chen, Dong ^{[1
]}

Chen, Constance P. ^{[4
]}

Spethman, Caroline ^{[5
]}

Bessonen, Kurt R. ^{[1
]}

Oliveira, Jennifer L. ^{[1
]}

Nguyen, Phuong L. ^{[1
]}

Reichard, Kaaren K. ^{[1
]}

Hoyer, James D. ^{[1
]}

Althoff, Simon D. ^{[1
]}

Roh, Dana J. ^{[1
]}

Miller, Mechelle A. ^{[1
]}

Yuan, Ji ^{[1
]}

Olteanu, Horatiu ^{[1
]}

Begna, Kebede ^{[6
]}

Tefferi, Ayalew ^{[6
]}

Alkhateeb, Hassan ^{[6
]}

Patnaik, Mrinal M. ^{[6
]}

Litzow, Mark R. ^{[6
]}

Al-Kali, Aref ^{[6
]}

Viswanatha, David S. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA

[2] Dartmouth Coll, Hanover, NH USA

[3] Wellesley Coll, Wellesley, MA USA

[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA

[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA

[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA

来源：

BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期

关键词：

CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;

D O I：

10.1038/s41408-022-00612-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[21] Cytogenetics and its prognostic value in myelodysplastic syndromes
Verhoef, GEG
Boogaerts, MA
ACTA HAEMATOLOGICA, 1996, 95 (02) : 95 - 101
[22] The prognostic value of LDH in myelodysplastic syndromes.
Wimazal, F
Sperr, WR
Kundi, M
Fonatsch, C
Thalhammer-Scherrer, R
Wessel, S
Meidlinger, P
Schwarzinger, I
Geissler, K
Lechner, K
Valent, P
BLOOD, 1999, 94 (10) : 288B - 288B
[23] Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromes
A Kuendgen
N Gattermann
U Germing
Leukemia, 2009, 23 : 182 - 184
[24] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes treated with azacitidine
Kamiya, Takahiro
Nakazato, Tomonori
MEDICAL ONCOLOGY, 2019, 36 (03)
[25] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes treated with azacitidine
Takahiro Kamiya
Tomonori Nakazato
Medical Oncology, 2019, 36
[26] Prognostic value of the controlling nutritional status score in patients with myelodysplastic syndromes
Chen, Qiuni
Chen, Kankan
Wang, Sumei
Zhang, Lijuan
Shi, Yuye
Tao, Shandong
He, Zhengmei
Wang, Chunling
Yu, Liang
FRONTIERS IN NUTRITION, 2022, 9
[27] Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes
Horny, Hans-Peter
Sotlar, Karl
Valent, Peter
LEUKEMIA RESEARCH, 2007, 31 (12) : 1609 - 1616
[28] Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes
Kewan, Tariq
Bahaj, Waled
Durmaz, Arda
Aly, Mai
Ogbue, Olisaemeka D.
Carraway, Hetty E.
Sekeres, Mikkael A.
Visconte, Valeria
Gurnari, Carmelo
Maciejewski, Jaroslaw P.
BLOOD, 2023, 141 (14) : 1768 - 1772
[29] MOLECULAR PATHOGENESIS AND PROGNOSTIC STRATIFICATION OF MYELODYSPLASTIC SYNDROMES
Cazzola, M.
HAEMATOLOGICA, 2022, 107 : 1 - 2
[30] Improving the prognostic evaluation of patients with lower risk myelodysplastic syndromes Reply
Garcia-Manero, G.
LEUKEMIA, 2009, 23 (01) : 185 - 185

← 1 2 3 4 5 →